Drug Daraxonrasib Doubles Survival For Advanced Pancreatic Cancer
New drug daraxonrasib has shown surprising survival gains in advanced pancreatic cancer and could reshape treatment for other tumors driven by the KRAS mutation, offering fresh hope where options have been painfully limited. A personal story opens this piece: a vibrant woman in her mid-40s received a pancreatic cancer diagnosis and was given only months...